What we know and what we want to know: About Biosimilars
Presenters: Louise Binder, SYSF Health Policy, Cathy Parker, Director Policy and International Collaboration – Health Canada, Helen Mai, Policy and Strategy Advisor, CADTH.
Objective: A panel discussion on Biosimilars in oncology, the approval process and the potential policy position for oncology drug reimbursement Discussion Points include: – Health Canada’s review and approval for sale – CADTH’S role in this area and their involvement with pCPA – Potential policy objectives and position for oncology drug reimbursement
When: Friday, January 19, 2018 1-2pm EST
Registration Link Below: